Pernix Therapeutics Logo Image

Pernix Therapeutics

Pernix Therapeutics Banner Image

Pernix Therapeutics has reached its limit for report views.

Please check back to see if Pernix Therapeutics has upgraded their profile page to allow their financial information to be viewed. In the meantime, here are a few annual reports from similar companies.

Most Recent Annual Report

2016 Annual Report and Form 10K

Pernix Therapeutics
Order Free Hardcopy

You can request a free hardcopy of this report mailed to you by clicking the button below.

Add Annual Report

Archived Annual Reports

  • Pernix Therapeutics
  • Pernix Therapeutics

About Pernix Therapeutics

51-200 Employees
Based in Morristown, New Jersey

Pernix Therapeutics Holdings, Inc. focuses on developing, manufacturing, marketing, and selling branded and generic pharmaceutical products for pediatric and adult indications in various therapeutic areas. Its products include CEDAX, a oral cephalosporin used for the treatment of mild to moderate acute bacterial exacerbations of chronic bronchitis, middle ear infection due to haemophilus influenza, or streptococcus pyogenes; NATROBA, a prescription medicine used to treat head lice in adults and children; and VERIPRED, a prescription drug product for the control of allergic conditions in adult and pediatric populations with seasonal or perennial allergic rhinitis, asthma, contact and atopic dermatitis, serum sickness, and drug hypersensitivity reactions.

NASDAQ (See More NASDAQ Companies)
Drug Manufacturers - Other (See More Drug Manufacturers - Other Companies)
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol